Spectropath
Atlanta
About Spectropath
Spectropath is a biomedical technology company developing innovative devices using novel electronic, optical, chemical, and software solutions that allow physicians to identify selected tissues, such as cancer, in real-time during surgery. Their primary goal is to introduce advanced Medical Imaging Solutions that will revolutionize the way physicians interact with the targeted surgical field while accelerating the quality of care that a patient receives. Their mission is to put the best quality devices, and the most advanced technology into the capable hands of the best physicians. Through this pairing of skills and technology, they can create the best possible results for patients and their families. Spectropath’s core technology directly addresses certain risks and doubt that exists in available treatment methods. As they strive to advance the current state of medicine, they hope to eliminate troubling questions that plague physicians and patients alike.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.9M
- Last round: Series Unknown (Jan 2014)
- Website: spectropath.com
- Phone: 404-665-4035
Industries & Categories
Biotechnology, Chemical, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/spectropath-1562885 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.